The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Experts urge early detection & better access to care
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
The programme will take place on the 2nd Sunday of every month
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
Subscribe To Our Newsletter & Stay Updated
